Remove Allergies Remove Dermatology Remove Licensing Remove Medicine
article thumbnail

Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer

The Pharma Data

Dr Graham is a medicines development expert and Infectious Diseases Epidemiologist with global Biotech and Pharma R&D experience in Phase I-IV therapeutics as well as in-vivo & in-vitro diagnostics, across many modalities. NEW YORK and LONDON, Jan. He has in depth Global Development Expertise (e.g.

article thumbnail

17 creams to STOP ITCHING FAST

Druggist

Topical steroids are not directly classified as anti-itch medicines; however, it is thought that reduced skin itchiness comes from controlling skin inflammation (ibid). Pharmacy-only medicines can only be purchased from pharmacies, including online chemists. Clobetasone has a narrow licensed use. very potent steroid creams.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bayer: successful start to 2021

The Pharma Data

This included net special gains of 15 million euros (Q1 2020: net special charges of 639 million euros), with income from a patent dispute related to the blood-clotting medicine Jiviâ„¢ more than offsetting the expenses for the ongoing restructuring program. in the Allergy & Cold category. EBIT increased by 23.4 percent to 2.59

Sales 40
article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

With each passing year, pharmaceutical companies around the globe strive to deliver cutting-edge medicines, therapies and vaccines that impact the lives of millions. In this in-depth article, we embark on a captivating journey to uncover the top 30 pharma and biotech companies that have been instrumental in shaping the future of medicine.

Sales 98
article thumbnail

Tezepelumab regulatory submission accepted and granted FDA Priority Review in the US for the treatment of patients with asthma

The Pharma Data

AstraZeneca’s Biologics License Application (BLA) for tezepelumab has been accepted and granted Priority Review for the treatment of asthma from the US Food and Drug Administration (FDA). Despite recent advances in severe asthma, many patients may not qualify for or respond well to current biologic medicines.

Trials 52
article thumbnail

CoolSculpting® by Allergan Aesthetics Expands Body Contouring Portfolio With CoolSculpting® Elite

The Pharma Data

American Society for Dermatologic Surgery (ASDS) consumer survey on cosmetic dermatologic procedures 2018 available at [link]. AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. N= 3,525 total study population.